We are pleased to announce that our abstract has been selected for an oral presentation at APASL 2024. The Asia-Pacific Association for the Study of Liver (APASL) Congress is an important event in the field of hepatology, bringing together experts from around the globe to discuss the latest advancements, research findings, and clinical insights.
Our presentation promises to contribute valuable insights to the conference program. We are honoured to have this platform to share our research and engage with fellow professionals in the field.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
